Pharmacovigilance – News and Features

Iron regulation – and the MEMO1 protein – could be a potential target for triple negative breast cancer treatments.

Scientists at St. Jude Children’s Research Hospital and Washington University School of Medicine found that T follicular helper cells determine the effectiveness of vaccine-induced immunity against flu.

A new technique may help reveal unknown benefits of existing drugs, according to a new study. The new approach, called decryptE, could help identify new applications for already approved drugs and take steps toward precision medicine.

Researchers discovered a hormone-like toxin in cone snail venom that mimics human somatostatin, regulating blood sugar and hormone levels with greater stability and specificity.

Participants on a self-directed dietary education program who had the greatest success at losing weight across a 25-month period consumed greater amounts of protein and fiber, a study found.

A new study suggests that Manuka honey could potentially be an alternative, natural option for breast cancer prevention and treatment.

Dr. Sergio Pérez Rosal explains why, in his opinion, “hope is not lost” and the therapeutic potential of psychedelics for the treatment of psychiatric disorders could still be unlocked. But what happens next must be firmly rooted in science.

CU Boulder researchers discovered that COVID-19 proteins left in the brain reduce cortisol levels, inflame the nervous system, and prime immune cells to overreact to stressors. This might explain the neurological symptoms of long COVID.

Researchers have developed a novel reagent that enhances the precision of drug synthesis. This innovative method introduces a new sulfur fluoride exchange (SuFEx) reagent that allows for highly controlled production of crucial sulfur-based molecules.

Job strain and effort-reward imbalance at work were associated with a greater chance of developing an abnormal heart rhythm condition, finds new study.